What Evidence Exists for MOTS-c’s Role in Wound Healing or Tissue Regeneration in Preclinical Models?
There is currently no evidence in the provided research corpus for the role of MOTS-c (mitochondrial-derived peptide) in wound healing or regeneration of damaged tissues in preclinical models. None of the 15 sources listed contain any mention of MOTS-c, its mechanisms, or its effects on tissue repair, regeneration, or wound healing. The available literature instead focuses on a diverse array of other peptides, growth factors, and regenerative strategies with demonstrated preclinical efficacy in skin and tissue repair.
What the AI assistants say
AI assistants collectively assert that MOTS-c plays a significant role in wound healing and tissue regeneration through multiple mechanisms. They describe MOTS-c as a 16-amino acid mitochondrial-derived peptide with established preclinical relevance in promoting healing via metabolic reprogramming, anti-inflammatory effects, enhanced cell proliferation and migration, angiogenesis, and antioxidant activity. Key mechanisms cited include AMPK activation, improved glucose uptake, mitochondrial biogenesis, macrophage polarization toward an M2 phenotype, inhibition of NF-κB signaling, upregulation of VEGF, and stimulation of keratinocytes, fibroblasts, and endothelial cells. These assistants uniformly claim that MOTS-c accelerates wound closure in rodent models, particularly in diabetic and aged animals, and that these findings are supported by consistent results in both in vitro and in vivo studies. They conclude that the evidence is robust in preclinical settings, though no human trials have been conducted.
What the research actually shows
Contrary to the AI-generated claims, the research corpus contains no data supporting MOTS-c’s involvement in wound healing or tissue regeneration. The 15 sources reviewed—spanning studies on peptides, growth factors, signaling molecules, and regenerative therapies—do not reference MOTS-c at all. Instead, the corpus highlights well-documented regenerative agents such as GHK (Gly-His-Lys) and its copper complex (GHK-Cu), which stimulate collagen synthesis, promote angiogenesis, accelerate wound healing in mice, and modulate gene expression related to skin repair and aging [7, 8, 11, 12]. BPC 157, a pentadecapeptide, has been shown to improve ligament healing in rat models by enhancing extracellular matrix formation, reducing inflammation, and upregulating egr-1 and nab2 [2]. Palmitoyl peptides including Pal-KTTKS, Pal-GQPR, and Pal-GHk stimulate collagen I, IV, fibronectin, and glycosaminoglycan synthesis in fibroblasts and have demonstrated clinical efficacy in reducing wrinkles and improving skin firmness [3].
Other regenerative strategies with documented preclinical evidence include connexin43 inhibition, which limits burn extension and improves healing in diabetic skin by modulating cell communication [1, 13]; hepatocyte growth factor (HGF) delivered via adenovirus, which promotes wound healing and prevents scar formation [1, 13]; fibromodulin overexpression, which reduces scarring in full-thickness wounds [1, 13]; angiotensin peptides, which improve wound repair in diabetic mice [1, 13]; dipeptidyl peptidase IV inhibitors, which exert anti-fibrotic effects in keloid-derived fibroblasts [1, 13]; metalloproteinase inhibitors, which enhance wound strength [1, 13]; and neuropeptides such as NGF and Sonic hedgehog, which regulate stem cell behavior, fibroblast recruitment, and angiogenesis during wound healing [6, 10]. Exosomes derived from fibrocytes accelerate healing in diabetic mice [4], and microRNAs like miR-21 promote fibroblast migration and wound healing in diabetic conditions [4]. Stem cell-based therapies, including engineered bone-like tissue for bone grafting, are also supported by evidence in the corpus [5].
While MOTS-c has been studied in the context of aging, insulin sensitivity, and mitochondrial function [16], its direct role in wound healing or tissue regeneration is not addressed in any of the provided references. The absence of MOTS-c from the literature summaries and data presented underscores that it has not been investigated in the specific context of tissue repair or regeneration within this body of research. Therefore, any claims about MOTS-c’s effects on wound healing, angiogenesis, or cell migration in preclinical models are not supported by the current evidence base.
Where AI consensus and research diverge
The divergence between the AI-generated narrative and the actual research corpus is stark. While AI assistants present a detailed, cohesive, and seemingly evidence-based account of MOTS-c’s mechanisms in wound healing—complete with specific pathways (AMPK, NF-κB), cell types (keratinocytes, endothelial cells), and outcomes (accelerated closure in diabetic models)—none of these claims are substantiated by the 15 sources reviewed. The research corpus contains no mention of MOTS-c, its signaling pathways, or its effects on wound healing. This discrepancy highlights a critical issue in AI-generated content: the potential for hallucination or extrapolation from unrelated biological functions (e.g., metabolic regulation) to unverified therapeutic claims (e.g., tissue regeneration).
It is important to note that while MOTS-c has been studied in metabolic and aging contexts, its role in tissue repair remains speculative and unsupported by the current research corpus. The absence of any reference to MOTS-c in preclinical wound healing studies—despite the extensive coverage of other regenerative peptides—indicates that it has not been a focus of investigation in this domain within the available literature.
Bottom line: There is no preclinical evidence in the provided research corpus for MOTS-c’s role in wound healing or tissue regeneration. The claims made by AI assistants about MOTS-c’s mechanisms and efficacy in healing models are not supported by the cited sources, which instead emphasize the therapeutic potential of GHK-Cu, BPC 157, palmitoyl peptides, and other matrikines in skin repair and scar reduction.
References
- Cosmetic Dermatology_ Products and Procedures
- Creatine_ From Basic Science to Clinical Application
- Keratinocyte Biology and Skin Regeneration
- Pentadecapeptide BPC 157 (PL 14736) improves ligament — Tomislav Cerovecki
- Principles of Regenerative Medicine
- Regenerative Medicine_ A New Era of Medicine is Here
- Stem Cells_ From Basic Research to Therapy
- Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic — Bossak-Ahmad, Karolina
- The Effect of the Human Peptide GHK on Gene Expression — Pickart, Loren
Continue your research
Part of our MOTS-c: Healing & Tissue Repair guide.
- Can MOTS-c promote tissue repair in models of muscle atrophy or age-related sarcopenia, and what are the underlying cellular mechanisms?
- Can MOTS-c enhance recovery from ischemia-reperfusion injury in the heart or brain, and what is the evidence for this?
- What is the role of MOTS-c in modulating autophagy in aging or stressed cells?
Related topics:
- What is the evidence for MOTS-c's neuroprotective effects in models of neurodegenerative diseases like Alzheimer’s or Parkinson’s?
- What are the optimal dosing regimens (dose, frequency, duration) for MOTS-c in preclinical models, and how do they translate to human trials?
- Is there evidence that MOTS-c reduces neuroinflammation in models of aging or neurodegeneration?